Book contents
- Core Topics in Cardiothoracic Critical Care
- Core Topics in Cardiothoracic Critical Care
- Copyright page
- Contents
- Contributors
- Foreword
- Preface to the Second Edition
- Link between Cardiothoracic Anaesthesia and Intensive Care: Which Patients are Admitted to Critical Care?
- Scoring Systems and Prognosis
- Abbreviations
- Section 1 Diagnosis
- Section 2 Practical Procedures
- Section 3 Therapeutic Intervention
- Section 4 Advanced Organ Support
- Section 5 Acute Disorders
- Section 6 Perioperative Care: The Patient Post Cardiac Surgery
- Section 7 Disease Management in the Cardiothoracic Intensive Care Unit: Incidence; Aetiology; Diagnosis; Prognosis; Treatment
- 44 Respiratory Disorders: Acute Respiratory Distress Syndrome
- 45 Cardiovascular Disorders: the Heart Failure Patient in the Intensive Care Unit
- 46 Neurological Aspects of Cardiac Surgery
- 47 Postoperative Delirium
- 48 Haematological Disorders and Cardiothoracic Intensive Care
- 49 Pregnancy and Cardiovascular Disorders
- 50 Paediatric Cardiac Intensive Care
- 51 Grown-up Congenital Heart Disease (GUCH) Patients in the Cardiothoracic Intensive Care Unit
- 52 Difficult to Wean from Mechanical Ventilation Patients in the Cardiothoracic Intensive Care Unit
- Section 8 Provision and Delivery of Cardiothoracic Intensive Care
- Exercise Answers
- Index
- References
48 - Haematological Disorders and Cardiothoracic Intensive Care
from Section 7 - Disease Management in the Cardiothoracic Intensive Care Unit: Incidence; Aetiology; Diagnosis; Prognosis; Treatment
Published online by Cambridge University Press: 15 June 2018
Book contents
- Core Topics in Cardiothoracic Critical Care
- Core Topics in Cardiothoracic Critical Care
- Copyright page
- Contents
- Contributors
- Foreword
- Preface to the Second Edition
- Link between Cardiothoracic Anaesthesia and Intensive Care: Which Patients are Admitted to Critical Care?
- Scoring Systems and Prognosis
- Abbreviations
- Section 1 Diagnosis
- Section 2 Practical Procedures
- Section 3 Therapeutic Intervention
- Section 4 Advanced Organ Support
- Section 5 Acute Disorders
- Section 6 Perioperative Care: The Patient Post Cardiac Surgery
- Section 7 Disease Management in the Cardiothoracic Intensive Care Unit: Incidence; Aetiology; Diagnosis; Prognosis; Treatment
- 44 Respiratory Disorders: Acute Respiratory Distress Syndrome
- 45 Cardiovascular Disorders: the Heart Failure Patient in the Intensive Care Unit
- 46 Neurological Aspects of Cardiac Surgery
- 47 Postoperative Delirium
- 48 Haematological Disorders and Cardiothoracic Intensive Care
- 49 Pregnancy and Cardiovascular Disorders
- 50 Paediatric Cardiac Intensive Care
- 51 Grown-up Congenital Heart Disease (GUCH) Patients in the Cardiothoracic Intensive Care Unit
- 52 Difficult to Wean from Mechanical Ventilation Patients in the Cardiothoracic Intensive Care Unit
- Section 8 Provision and Delivery of Cardiothoracic Intensive Care
- Exercise Answers
- Index
- References
- Type
- Chapter
- Information
- Core Topics in Cardiothoracic Critical Care , pp. 402 - 407Publisher: Cambridge University PressPrint publication year: 2018
References
Further Reading
Bhave, P, McGiffin, D, Shaw, J, et al. Guide to performing cardiac surgery in patients with hereditary bleeding disorders. Journal of Cardiac Surgery. 2015; 30: 61–69.Google Scholar
Despotis, GJ, Avidan, MS, Hogue, CW. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Annals of Thoracic Surgery. 2001; 72: S1821–S1831.Google Scholar
Dyke, CM, Smedira, NG, Koster, A, et al. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. Journal of Thoracic and Cardiovascular Surgery. 2006; 131: 533–539.CrossRefGoogle ScholarPubMed
Levy, JH. Heparin resistance and antithrombin: should it still be called heparin resistance?[comment]. Journal of Cardiothoracic and Vascular Anesthesia. 2004; 18: 129–130.CrossRefGoogle ScholarPubMed
Levy, JH, Despotis, GJ, Szlam, F, Olson, P, Meeker, D, Weisinger, A. Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study. Anesthesiology. 2002; 96: 1095–1102.Google Scholar
Levy, JH, Faraoni, D, Spring, JL, Douketis, JD, Samama, CM. Managing new oral anticoagulants in the perioperative and intensive care unit setting. Anesthesiology. 2013; 118: 1466–1474.Google Scholar
Levy, JH, Key, NS, Azran, MS. Novel oral anticoagulants: implications in the perioperative setting. Anesthesiology. 2010; 113: 726–745.Google Scholar
Levy, JH, Montes, F, Szlam, F, Hillyer, CD. The in vitro effects of antithrombin III on the activated coagulation time in patients on heparin therapy. Anesthesia & Analgesia. 2000; 90: 1076–1079.Google Scholar
Levy, JH, Weisinger, A, Ziomek, CA, Echelard, Y. Recombinant antithrombin: production and role in cardiovascular disorder. Seminars in Thrombosis and Hemostasis. 2001; 27: 405–416.CrossRefGoogle ScholarPubMed
Mannucci, PM. Treatment of von Willebrand’s disease. New England Journal of Medicine. 2004; 351: 683–694.Google Scholar
Sniecinski, RM, Chandler, WL. Activation of the hemostatic system during cardiopulmonary bypass. Anesthesia & Analgesia. 2011; 113: 1319–1333.CrossRefGoogle ScholarPubMed
Sniecinski, RM, Hursting, MJ, Paidas, MJ, Levy, JH. Etiology and assessment of hypercoagulability with lessons from heparin-induced thrombocytopenia. Anesthesia & Analgesia. 2010; 112: 46–58.Google Scholar
Warkentin, TE, Sheppard, JI, Moore, JC, Sigouin, CS, Kelton, JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. Journal of Thrombosis and Haemostasis. 2008; 6: 1304–1312.Google Scholar